Tag: NASDAQ:CARA

Analysts Viewpoint

Cara Therapeutics Inc’s recent filing unveils that its SEC’Y; CHIEF COMPLIANCE & G.C. Terrillion Scott unloaded Company’s shares for reported

Insiders Updates

In a filing, Cara Therapeutics Inc revealed its SEC’Y; CHIEF COMPLIANCE & G.C. Terrillion Scott unloaded Company’s shares for reported

Insiders Updates

In a filing, Cara Therapeutics Inc revealed its PRESIDENT AND CEO Posner Christopher unloaded Company’s shares for reported $5192.0 on